NE
NeoGenomics, Inc.
NEO · NASDAQ
$19.41 -1.87% (-$0.37)
1M +18.28%
Market Cap $498.7M
P/E Ratio -
Div. Yield -
ROE 6.31%
Bulios Fair Price
$10.35
46.7% downside
Trenutna cena
$19.41
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NEO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
44 /100
Fair P/B 0.63x
EV/EBITDA 62.20x
P/S 0.65x
Growth
60 /100
Stable Book val. growth 5.71%
Rev. growth 12.58%
FCF growth N/A
Profitability
17 /100
Weak Op. margin 8.63%
Gross margin 42.92%
FCF margin 0.96%
Quality
7 /100
Poor ROA 3.84%
ROIC 5.03%
Asset turnover 0.57x
Debt
38 /100
Moderate Int. coverage -20.37x
Debt/Equity 0.57x
Net debt/EBITDA 23.50x
Stability
50 /100
Moderate EPS volatility 37.95%
Beta 1.75x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NEO
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Anthony Zook
Employees
2,500
Headquarters
Fort Myers
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report